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a  b  s  t  r  a  c  t
Group A rotaviruses are the main causative agent of infantile gastroenteritis. The segmented
nature of the viral genome allows reassortment of genome segments, which can generate
genetic variants. In this study, we characterized the diversity of the VP7, VP4 (VP8*), VP6,
NSP4, and NSP5 genes of the rotaviruses that circulated from 2005 to 2011 in the Triângulo
Mineiro (TM) region of Brazil. Samples with genotypes G2 (sublineages IVa-1 and IVa-3), G1
(sublineage I-A), G9 (lineage III), G12 (lineages II and III), G8 (lineage II), G3 (lineage III), P[4]
(sublineages IVa and IVb), P[8] (sublineages P[8]-3.6, P[8]-3.3, and P[8]-3.1), I2 (lineage VII), E2
(lineages VI, XII, and X), and H2 (lineage III) were identiﬁed. The associations found in the
samples were G1, G9, or G12 with P[8]-I1-E1-H1; G2 or G8 with P[4]-I2-E2-H2; G12 with I3-E3-
H6;  and G3 with P[4]-I2-E3-H3 (previously unreported combination). Reassortment events
in  G2P[4] strains and an apparent pattern of temporal segregation within the lineages were
observed. Five TM samples contained genes that exhibited high nucleotide and amino acid
identities with strains of animal origin. The present study includes a period of pre- and post-
introduction of rotavirus vaccination in all Brazilian territories, thereby serving as a basis for
monitoring changes in the genetic constitution of rotaviruses. The results also contribute
to  the understanding of the diversity and evolution of rotaviruses in a global context.©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
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diarrheal disease in children. In 2008, the virus was associ-
ated with the deaths of 453,000 children less than 5 yearsan  open acces
ntroductionhe group A rotavirus (RVA), a member of the genus Rotavirus
n the family Reoviridae,  is the main causative agent of severe
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The viral particle is non-enveloped and composed of 11
segments of double-stranded RNA surrounded by a triple-
layered protein capsid. The viral genome encode six structural
(VP1–VP4, VP6 and VP7) and six non-structural (NSP1–NSP6)
proteins. The outer capsid proteins, VP7 and VP4 (cleaved by
trypsin into VP5* and VP8*), are involved in the attachment
and entry during viral replication in host cells, and each can
independently induce the production of neutralizing antibod-
ies. The serotypes deﬁned by VP7 and VP4, as well as their
encoding genes, are used to classify rotaviruses into G and
P genotypes, respectively, based on a widely used binomial
system.2 Previous studies have demonstrated that RVAs of
genotypes G1, G2, G3, G4, G9, and G12, combined with geno-
types P[4] or P[8], are most prevalent among the strains that
cause human infection.3
Events such as point mutations, rearrangements, inter-
species transmissions, and reassortments occurring during
co-infections with different strains can generate genetic vari-
ants with vast inter- and intragenotypic diversity. This high
variability and observed ﬂuctuations in the prevalence of
dominant genotypes throughout epidemic seasons represent
a major challenge for immunization efforts using vaccines
currently available for the prevention of severe infections
caused by RVAs in many  countries. To better characterize
the diversity and evolutionary aspects of rotaviruses, a new
classiﬁcation system based on the 11 segments of the RVA
genome has recently been proposed, which emphasizes the
importance of analyzing other genes in addition to those
that encode for the VP7 and VP4 proteins.4 In this lat-
ter classiﬁcation, the VP7-VP4-VP6-VP1-VP2-VP3-NSP1-NSP2-
NSP3-NSP4-NSP5/6-encoding gene segments are classiﬁed as
Gx-P[x]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx (x indicates the num-
ber of the genotype), respectively. Genes 6, 10, and 11 encode
the VP6, NSP4, and NSP5 proteins, respectively. The VP6
protein has been studied as a possible target for vaccine devel-
opment, and studies in animals have demonstrated protective
immune responses induced by VP6 protein immunization.5
NSP4 is involved in viral morphogenesis and has enterotoxin-
like activity.6 Last, NSP5 is essential for viroplasm formation,
Table 1 – Selected RVA G/P types collected from children with g
Mineiro, Brazil, from 2005 to 2011.
G/P type City 2005–2006 2007 
Collected/
selected
Collected/
selected
C
G1P[8] UB 3/1 – 
G2P[4] UB 25/4 33/3 
IP – – 
G9P[8] UB 7/4 – 
G3P[4]a IP – – 
GNTP[8] UB 2/2 – 
G3P[NT] IP – – 
GNTP[NT] UB 2/2 – 
Mixed UB – – 
IP – – 
Total 39/13 33/3 
UB, Uberaba; IP, Uberlândia; NT, non-typed.
a Typed as G3 by PCR but determined to be G8 by sequence analysis. b i o l o g y 4 7 (2 0 1 6) 731–740
genome replication, and virion assembly, and its gene is most
frequently associated with rearrangement events.2
Since 2005, surveillance of circulating RVA strains has been
conducted in the Triângulo Mineiro (TM) region of Minas
Gerais State, Brazil. The studies showed that different G-types
associated with P[8] co-circulated in 2005 and also that G2P[4]
had emerged by mid-2006, continuing as the prevalent geno-
type until 2010.7–9 In this study, we characterized the diversity
of the VP7, VP4 (VP8* subunit), VP6, NSP4, and NSP5 genes of
representative RVA strains that circulated during six seasons
(2005–2011) in the TM region.
Materials  and  methods
Sample  collection
Twenty-seven representative RVA strains from a collection of
117 rotavirus-positive fecal samples from Uberaba (2005–2009
and 2011) and Uberlândia (2008–2011) were selected based
on their electropherotypes and VP7 and VP4 genotypes, pre-
viously characterized in three-laboratory-based surveillance
studies (Table 1).7–9 These previous studies analyzed fecal
specimens from children who presented acute gastroen-
teritis, which were provided by laboratories Jorge Furtado
Medicina Diagnóstica (Uberaba) or IPAC Medicina Diagnós-
tica (Uberlândia). Information on the vaccination history of
the patients was not available. The 27 representative sam-
ples were collected from outpatients and inpatients from one
hospital in Uberaba and two hospitals in Uberlândia. This
study was approved by the Human Research Ethics Commit-
tee of Universidade Federal do Triângulo Mineiro (protocol
CEP/UFTM/672/06).
RNA  extraction,  reverse  transcription  polymerase  chain
reaction  (RT-PCR),  and  nucleotide  (nt)  sequencingThe fecal specimens were subjected to nucleic acid
extraction,10 and reverse transcription was carried out
using random primers (Invitrogen, Carlsbad, CA, USA) and
astroenteritis in Uberaba and Uberlândia, Triângulo
2008 2009 2010 2011
ollected/
selected
Collected/
selected
Collected/
selected
Collected/
selected
– – – –
5/2 – – –
19/3 – 16/3 –
– – – –
– – – 1/1
– – – –
– 1/1 – –
– – – 1/1
– 1/0 – –
1/0 – – –
25/5 2/1 16/3 2/2
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urine leukemia virus reverse transcriptase (Promega, Madi-
on, WI,  USA) according to the manufacturers’ instructions.
he complementary DNA generated by the RT reaction was
hen used for the ampliﬁcation of all genes. The primers and
eaction conditions for ampliﬁcation of each target gene were
ased on previously described protocols as follows: primers
P7-F and VP7-R for partial (nt positions 49 to 933) VP7 gene11;
P4-F and VP4-R for the VP8* subunit (nt positions 132 to 795)
f the VP4 gene12; JRG30(+) and JRG31(−)  for a full-length gene
nt positions 1 to 738) encoding the NSP4 protein13; VP6-F and
P6-R for a partial gene (nt positions 747 to 1126) encoding
he VP6 protein14; and GEN-NSP5-F and GEN-NSP5-R for a
ull-length gene (nt positions 1 to 667 or to 1043) encoding
he NSP5 protein.15 PCR products were puriﬁed using the
asyPrep Gel/PCR Puriﬁcation Mini Kit (EasyPath, São Paulo,
P, Brazil), separated by agarose gel electrophoresis, and then
uantiﬁed by comparing the band intensities with those of
he Low DNA Mass Ladder (Invitrogen, Carlsbad, CA, USA).
he DNA fragments were then sequenced in both directions
ith the same primers as used for the PCRs using the BigDye®
erminator Cycle Sequencing Kit v. 3.1 and an ABI 3130
enetic Analyzer (Applied Biosystems, Foster City, CA, USA).
enotype  assignment  and  phylogenetic  analysis
he VP7, VP8*, VP6, NSP4, and NSP5 gene sequences were
urated with the Geneious software (Biomatters Ltd., Auck-
and, New Zealand). To identify the genotypes and evaluate the
enetic diversity, the TM samples were compared with the ref-
rence strains representing distinct genotypes, lineages, and
ublineages and with most similar ﬁeld samples from different
ontinents, as well as with vaccine strains. The lineages and
ublineages of G2, P[4], I2, E2, and H2 samples were previously
uggested by Giammanco et al.,16 whereas the G1, G9, G12, G8,
3, and P[8] lineages and sublineages were described by Phan
t al.,17,18 Rahman et al.,19 Ianiro et al.,20 Ndze et al.,21 and da
ilva et al.,22 respectively. All sequences of the ﬁeld and refer-
nce strains were retrieved from GenBank. Alignments were
erformed using MUSCLE (Multiple Sequence Comparison
y Log-Expectation) and analyzed with the maximum likeli-
ood algorithm.23,24 The best-ﬁt model of sequence evolution
as estimated by jModelTest according to the Bayesian Infor-
ation Criterion, and phylogenetic trees were constructed
or each gene. The maximum-likelihood trees were gener-
ted using selected models of nt substitution, GTR+I+G (VP7),
KY+G (VP8* and NSP5), HKY+G+I (VP6), and TrN+G (NSP4),
n the Molecular Evolutionary Genetics Analysis 5.1 software
MEGA Team, Japan). The nomenclature of all rotavirus strains
n the trees is listed according to Matthijnssens et al.25 The UB,
P and MG  abbreviations in the nomenclature of the TM sam-
les represent Uberaba, Uberlândia, and Minas Gerais State,
espectively.
ucleotide  sequence  accession  numbers
he nucleotide sequences were deposited in the GenBank
atabase, and the accession numbers are: KF938698–KF938771
or the G2P[4] samples and KR018449–KR018504 for the other
-types. The accession numbers of the strains retrieved from
enBank are shown at the end of each name in the trees.o l o g y 4 7 (2 0 1 6) 731–740 733
Results
A total of 130 nt consensus sequences were obtained for the
27 representative TM samples. In four of the samples, at least
one of the ﬁve target genes was not ampliﬁed with the primers
used.
Based on the VP7 gene, six genotypes were characterized:
G1, G2, G3, G8, G9, and G12 (Fig. 1a). The TM G2 samples
shared 95.3–100% and 96.8–100% nt and amino acid (aa) iden-
tity, respectively. They belonged to lineage IV, segregating into
sublineages IVa-3 and IVa-1. The TM G1 sample belonged to
lineage I, sublineage I-A, and shared 94% nt and 95.3% aa
identity with the RotarixTM vaccine strain of lineage II. The
TM G9 samples belonged to lineage III and shared 97.3–100%
nt and aa identity. The TM G12 samples shared 96.4–100%
and 96.7–100% nt and aa identity, respectively. These samples
clustered into lineages II (with strains of G12P[9] combina-
tion) and III (with strains of G12P[8] and G12P[6] combinations).
The TM G8 sample belonged to lineage II; it exhibited high nt
(99.3–99.9%) and aa (99.1–100%) identities with other contem-
porary human P[4] samples from Italy (SS56), USA (USRo104),
Germany (GER1H-09), and Brazil (RN19461-08). The TM G3
sample fell into lineage III, in a separate sub-cluster from the
prototype strain (AU-1). They only shared 90.7% nt and 94.9%
aa identity, but the TM G3 sample showed higher identity (nt,
99.1%; aa, 98.4%) with a cat sample (BA222) isolated from Italy.
Based on the VP8* gene, the TM samples were distributed
among P[8]- and P[4]-types (Fig. 1b). The TM P[4] sam-
ples shared 96.2–100% and 95.2–100% nt and aa identity,
respectively. These samples belonged to lineage IV and split
into sublineages IVa and IVb. The TM P[8] samples showed
96.5–100% nt and 95.6–100% aa identity. They belonged to lin-
eage P[8]-3 and were divided between sublineages P[8]-3.1,
P[8]-3.3, and P[8]-3.6, regardless of the combinations with the
G genotypes.
Based on the VP6 gene, the TM samples belonged to I1, I2,
and I3 genotypes (Fig. 1c). The TM I2 strains showed 95.9–100%
and 99.1–100% nt and aa identity, respectively, and clustered
together with other strains identiﬁed within lineage VII world-
wide. All I2 strains shared P[4] genotype speciﬁcity and formed
two main sub-clusters (a and b) with their separation sup-
ported by a high bootstrap value (100%). The TM samples that
grouped into cluster I3 exhibited G12 speciﬁcity and showed
high nt (99.4–100%) and aa (100%) identities to the reference
sample (T152) of the G12P[9] combination. The TM I1 sam-
ples shared an nt identity of 94.7–100% and an aa identity of
98.2–100%. They grouped apart from the prototype (Wa) and
vaccine-derived (RotarixTM) strains. The TM I1 samples shared
87.3–100% nt and 95.6–100% aa identity with these reference
strains, and the majority shared P[8] genotype speciﬁcity.
Based on the NSP4 gene, the TM samples were distributed
among the E2, E1, and E3 genotypes (Fig. 1d). The TM E2
samples shared 85.0–100% nt and 94.0–100% aa identity. They
were subdivided between the clusters of lineages VI, X, and
XII, composed of strains with P[4] speciﬁcity. The TM sam-
ples of lineage VI formed two phylogenetic sub-clusters (a
and b), with their separation supported by a high bootstrap
value (99%). TM strains UB-239 and UB-226 displayed high nt
(95.7–100%) and aa (97.7–100%) identities with the bovine 1603
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 RVA/Human-wt/BRA/UB-320_MG/2007/G2P[4 ]
 RVA/Human-wt/BRA/UB-354_MG/2007/G2P[4 ]
 RVA/Human-wt/BRA/UB-432_MG/2008/G2P[4 ]
 RVA/Human-wt/BGD/Dhaka26-06/2006/G2P[4]_EF690795
 RVA/Human-wt/BRA/RJ12398/2006/G2P[4]_KJ638611
 RVA/Human-wt/ECU/2012826190/2011/G2P[4]_KC951945
 RVA/Human-wt/BRA/IP-71_MG/2008/G2P[4]
 RVA/Human-wt/BRA/IP-346_MG/2010/G2P[4 ]
 RVA/Human-wt/USA/2007719869/2007/G2P[4]_KC44288 6
 RVA/Human-wt/BRA/IP-38_MG/2008/G2P[4 ]
 RVA/Human-wt/BRA/RJ17745/2010/G2P[4]_KJ638629
 RVA/Human-wt/AUS/CK20024/2006/G2P[4]_KC443702
 RVA/Human-wt/ITA/PA83/2007/G2P[4]_KC178812
 RVA/Human-wt/ARG/Arg2852/2010/G2P[4]_KF920559
 RVA/Human-wt/BRA/IP-47_MG/2008/G2P[4 ]
 RVA/Human-wt/BRA/UB-433_MG/2008/G2P[4 ]
 RVA/Human-wt/BRA/IP-393_MG/2010/G2P[4]
 RVA/Human-wt/BRA/BA17990/2010/G2P[4]_KJ638630
 RVA/Human-wt/CAN/RT008-09/2009/G2P4_JQ069521
IVa-3
 RVA/Human-wt/JPN/01P017/2001/G2P[4]_AB821335
 RVA/Human-wt/BRA/UB-299_MG/2007/G2P[4 ]
 RVA/Human-wt/BRA/IP-364_MG/2010/G2P[4 ]
 RVA/Human-wt/BRA/UB-226_MG/2006/G2P[4 ]
 RVA/Human-wt/BRA/UB-239_MG/2006/G2P[4 ]
 RVA/Human-wt/ARG/Arg2389/2007/G2P[4]_GQ154537
 RVA/Human-wt/BRA/MT11258/2005/G2P[4]_KJ638603
 RVA/Human-wt/BRA/UB-154_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-170_MG/2006/G2P[4 ]
 RVA/Human-wt/USA/LB2772/2005-06/G2P[4]_HM467956
IVa-1
IVa
 RVA/Human-wt/CHN/Tb-Chen/1996/G2P[4]_AY787646
Lineage IV
 RVA/Human-wt/AUS/95A/1995/G2PX_HRU73955
 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]_GU565068 Lineage II
 RVA/Human-tc/USA/DS-1/1976/G2P[4]_AB118023
 RVA/Human-wt/AUS/Hu5/1977/G2PX_X0057 2 Lineage I
G2
 RVA/Human-tc/JPN/KU/1974/G1P[8]_D16343
 RVA/Human-tc/USA/Wa/1974/G1P[8]_JX406755 Lineage III
Lineage II
 RVA/Vaccine/USA/Rotarix-A41CB052A/1988/G1P1A[8]_JN849114
I-B
 RVA/Human-wt/VNM/VN-281/2003/G1Px_DQ508167
I-C
 RVA/Human-wt/URY/Mvd9816/1996-9/G1Px_AF480293
I-E
 RVA/Human-tc/CHN/Chi-45/1987/G1Px_GAU2637 1
I-D
 RVA/Human-wt/JPN/6916/2005-6/G1P[8]_EF079067
 RVA/Human-wt/BGD/Dhaka8-02/xxxx/G1P[8]_AY631049
 RVA/Human-wt/AUS/CK00006/2004/G1P[8]_JF490143
 RVA/Human-wt/ITA/PR1598/2005/G1P[8]_HM245031
 RVA/Human-wt/BRA/ba6599-03/2003/G1P[8]_KM027206
 RVA/Human-wt/BRA/UB-09_MG/2005/G1P[8 ]
I-A
Lineage I
G1
 RVA/Human-wt/BRA/UB-157_MG/2006/G9P[8 ]
 RVA/Human-wt/BRA/UB-208_MG/2006/G9P[8 ]
 RVA/Human-wt/BRA/BA12680/2006/G9P[8]_KJ454491
 RVA/Human-wt/BRA/UB-16_MG/2005/G9P[8]
 RVA/Human-wt/BEL/B3458/2003/G9P[8]_EF990708
 RVA/Human-wt/JPN/OT-7/2008/G9P[8]_FJ695604
 RVA/Human-wt/ARG/Arg2090/2007/G9P[8]_GQ154523
 RVA/Human-wt/BRA/ro13270/06/2006/G9P[8]_FJ794015
 RVA/Human-wt/BRA/UB-169_MG/2006/G9P[8]
 RVA/Human-wt/RUS/RUS-Nov06-1289/2006/G9P[8]_FJ529393
 RVA/Human-wt/ITA/MAR37/2006/G9P[8]_EF150339
 RVA/Human-wt/DEU/GER96-08/2008/G9P[8]_GU392986
 RVA/Human-wt/BRA/UB-558_MG/2011/G9P[8 ]
 RVA/Human-wt/CHN/JS10-15/2012/G9P[8]_KF113010
Lineage III
 RVA/Human-tc/JPN/F45/1987/G9P[8]_AB180970
 RVA/Human-tc/USA/WI61/1983/G9P[8]_AB180969 Lineage I
G9
 RVA/Human-wt/BRA/UB-144_MG/2006/G12P x
 RVA/Human-wt/BRA/UB-150_MG/2006/G12P x
 RVA/Human-wt/PRY/1471SR/2006/G12P[9]_KJ412580
 RVA/Human-tc/THA/T152/1998/G12P[9]_AB071404
 RVA/Human-wt/JPN/K12/1999/_G12P[9]_AB186120
 RVA/Human-wt/BRA/PE15776/2008/G12P[9]_KF907303
Lineage II
 RVA/Human-wt/BGD/N26/2002/G12P[6]_DQ14668 7
 RVA/Human-wt/KOR/CAU195/200x/G12P[6]_EF059916
 RVA/Human-wt/GBR/MV404-02/2002/G12P[6]_DQ501280
 RVA/Human-wt/USA/US6588/2005/G12P[8]_FJ152110
 RVA/Human-wt/BRA/RJ12419/2006/G12P[8]_KF907305
 RVA/Human-wt/BRA/UB-146_MG/2006/G12P[8 ]
Lineage III
G12
 RVA/Human-wt/ITA/SS56/2011/G8P[4]_KC870004
 RVA/Human-wt/USA/US09Ro104/2009/G8P[4]_JN711112
 RVA/Human-wt/DEU/GER1H-09/2009/G8P[4]_GQ414545
 RVA/Human-wt/BRA/IP-447_MG/2011/G8P[4]
 RVA/Human-wt/BRA/RN19461-08/2008/G8Px_JX844064
Lineage II
 RVA/Human-tc/IND/69M/1980/G8P[10]_EF672560
 RVA/Human-tc/KEN/B12/1987/G8P[1]_HM627547 Lineage III
G8
Lineage I
 RVA/Human-wt/BEL/B4106/2000/G3P[14]_AY740736
 RVA/Human-tc/JPN/AU-1/1982/G3P[9]_D86271
 RVA/Human-wt/BRA/RS16838/2009/G3P8_KJ454506
 RVA/Human-tc/USA/CC425/1997/G3P[9]_AJ311738
 RVA/Human-wt/MDG/02.3073/2008-9/G3P[9]_HQ405259
 RVA/Human-wt/BRA/IP-218_MG/2009/G3P[4 ]
 RVA/Cat-wt/ITA/BA222/2005/G3P[9]_GU827411
 RVA/Human-wt/FRA/R1320/2007/G3Px_HM03551 3
 RVA/Human-wt/RUS/01154/2011/G3P[9]_JX08802 1
Lineage III G3
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Fig. 1 – Maximum-likelihood phylogenetic analysis based on the VP7 (a), VP8* (b), VP6 (c), NSP4 (d), and NSP5 (e) gene
nucleotide sequences of Triângulo Mineiro (TM) strains and the sequences from the GenBank database. The numbers at the
nodes indicate bootstrap values (1000 replicates), and only values above 70% are shown. The trees are drawn to scale, with
the branch lengths measured as the number of substitutions per site. The TM samples are marked with a solid circle, and
the reference strains of each lineage and sublineage are marked with an open triangle. The uppercase letters followed by
Arabic numerals, Roman numeral, and lowercase letters represent different genotypes, lineages, and sublineages,
respectively, except for lineages and sublineages of the P[8] genotype, which are indicated by Arabic numerals, and
sublineages of G1 strains, which are indicated by uppercase letters.
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 RVA/Human-wt/BRA/12589_06RJ/2006/G2P[4]_HM066019
 RVA/Human-wt/BRA/UB-320_MG/2007/G2P[4]
 RVA/Human-wt/BRA/UB-354_MG/2007/G2P[4]
 RVA/Human-wt/BRA/IP-218_MG/2009/G3P[4]
 RVA/Human-wt/BRA/UB-432_MG/2008/G2P[4]
 RVA/Human-wt/BRA/IP-71_MG/2008/G2P[4]
 RVA/Human-wt/BRA/UB-299_MG/2007/G2P[4]
 RVA/Human-wt/PRY/1504SR/2007/G2P[4]_KJ627001
 RVA/Human-wt/MEX/MX05-234/2005/G2P[4]_JX012342
 RVA/Human-wt/USA/LB2744/2005-06/G2P[4]_HM467941_1
 RVA/Human-wt/BRA/UB-239_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-154_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-170_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-226_MG/2006/G2P[4]
 RVA/Human-wt/RUS/Nov04-H391/2004/G2P[4]_FJ919248
 RVA/Human-wt/BRA/IP-447_MG/2011/G8P[4]
 RVA/Human-wt/DEU/GER1H-09/2009/G8P[4]_GQ414543
 RVA/Human-wt/USA/US09Ro104/2009/G8P[4]_JN711111
 RVA/Human-wt/ITA/SS65/2011/G8P[4]_KC870011
IVa
 RVA/Human-wt/BRA/IP-38_MG/2008/G2P[4]
 RVA/Human-wt/BRA/IP-346_MG/2010/G2P[4]
 RVA/Human-wt/USA/2007719869/2007/G2P[4]_KC442884
 RVA/Human-wt/IRL/CIT-H96/200X/G2P[4]_HQ667789
 RVA/Human-wt/BRA/MA19112/2010/G2P[4]_KJ940113
 RVA/Human-wt/ITA/PA130/2010/G2P[4]_KC178790
 RVA/Human-wt/CAN/RT008-09/2009/G2P[4]_JQ069684
 RVA/Human-wt/AUS/CK20035/2006/G2P[4]_KC443403
 RVA/Human-wt/BRA/UB-433_MG/2008/G2P[4]
 RVA/Human-wt/RUS/Omsk08-336/2008/G2P[4]_GU356622
 RVA/Human-wt/BRA/IP-364_MG/2010/G2P[4]
 RVA/Human-wt/BRA/PE17886/2010/G2P[4]_KJ940101
 RVA/Human-wt/BRA/IP-47_MG/2008/G2P[4]
 RVA/Human-wt/BRA/IP-393_MG/2010/G2P[4]
IVb
 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]_AY787644
Lineage IV
 RVA/Human-tc/AUS/RV5/XXXX/G2P[4]_M32559
 RVA/Human-tc/USA/DS-1/1976/G2P[4]_HQ650119
Lineage I
P[4]
 RVA/Human-tc/USA/Wa/1974/G1P1A[8]_L34161
 RVA/Vaccine/USA/Rotarix-A41CB052A/1988/G1P1A[8]_JN849113
P[8]-1
 RVA/Human-tc/BRA/1054/xxxx/G5P[8]_GAU41004
 RVA/Human-wt/JPN/F45/1987/G1P[8]_U30716
P[8]-2
 RVA/Human-wt/BRA/UB-169_MG/2006/G9P[8]
 RVA/Human-wt/ARG/Arg2668/2009/G12P[8]_KF920585
 RVA/Human-wt/BEL/BE00028/2007/G1P[8]_HQ392229
 RVA/Human-wt/CAN/RT099-07/2008/G1P[8]_JQ069658
 RVA/Human-wt/BRA/se17120-09/2009/G1P[8]_JQ926477
P[8]-3.6
 RVA/Human-wt/BRA/UB-558_MG/2011/G9P[8]
 RVA/Human-wt/RUS/Nov11-N1776/2011/GxP[8]_JQ613162
 RVA/Human-wt/CAN/RT188-07/2008/G1P[8]_JQ069680
 RVA/Human-wt/SVN/SI-1975/12/2012/G9P[8]_KJ432858
 RVA/Human-wt/ARG/Arg7338/2009/G3P[8]_KJ583177
 RVA/Human-wt/BRA/RS16823/2009/G3P[8]_KJ454540
 RVA/Human-wt/BRA/rj7335/2003/G9P[8]_DQ857916
 RVA/Human-wt/BRA/rj20109/2011/G3P[8]_JX437059
P[8]-3.3
 RVA/Human-wt/BRA/UB-146_MG/2006/G12P[8]
 RVA/Human-wt/BRA/UB-142_MG/2006/GXP[8]
 RVA/Human-wt/USA/VU05-06-72/2005/G12P[8]_JF790298
 RVA/Human-wt/BRA/RJ12419/2006/G9P[8]_KJ454583
 RVA/Human-wt/THA/16vp4w/xxxx/GxP[8]_DQ674938
 RVA/Human-wt/BRA/UB-09_MG/2005/G1P[8]
 RVA/Human-wt/AUS/CK00006/2004/G1P[8]_JF490146
 RVA/Human-wt/BRA/ba7712/2003/G1P[8]_KM027083
 RVA/Human-wt/BEL/B3458/2003/G9P[8]_EF990707
 RVA/Human-wt/BRA/rj8224/2004/G9P[8]_FN179468
 RVA/Human-wt/PRY/615SR/2004/G9P[8]_KJ626919
 RVA/Human-wt/BRA/UB-208_MG/2006/G9P[8]
 RVA/Human-wt/BRA/UB-157_MG/2006/G9P[8]
 RVA/Human-wt/BRA/BA12680/2006/G9P[8]_KJ454584
 RVA/Human-wt/BRA/UB-16_MG/2005/G9P[8]
P[8]-3.1
P[8]-3
P[8]
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 RVA/Human-wt/BRA/IP-364_MG/2010/G2P[4]
 RVA/Human-wt/BRA/IP-393_MG/2010/G2P[4]
 RVA/Human-wt/DEN/W31705/2010/G9P[4]_KP013513
 RVA/Human-wt/MEX/1153/2009/G9P[4]_JX978837
 RVA/Human-wt/USA/VU10-11-5/2011/G2P[4]_KF716347
 RVA/Human-wt/BRA/UB-320_MG/2007/G2P[4]
 RVA/Human-wt/BRA/UB-354_MG/2007/G2P[4]
 RVA/Human-wt/BRA/15988_08BA/2008/G2P[4]_HM066153
 RVA/Human-wt/BRA/UB-432_MG/2008/G2P[4]
 RVA/Human-wt/BRA/RJ17745/2010/G2P[4]_KJ721698
 RVA/Human-wt/BRA/IP-346_MG/2010/G2P[4]
 RVA/Human-wt/USA/2007719869/2007/G2P[4]_KC442885
 RVA/Human-wt/BRA/IP-38_MG/2008/G2P[4]
 RVA/Human-wt/BRA/IP-218_MG/2009/G3P[4]
 RVA/Human-wt/ITA/PA133/2011/G2P[4]_KC178806
 RVA/Human-wt/CAN/RT008-09/2009/G2P4_JQ069601
 RVA/Human-wt/BRA/15898_08MG/2008/G2P[4]_HM066149
 RVA/Human-wt/BRA/IP-47_MG/2008/G2P[4]
 RVA/Human-wt/RUS/Nov12-N3952/2012/G2P[4]_KF661445
 RVA/Human-wt/DEN/H27897/2010/G9P[4]_KP013509
 RVA/Human-wt/BRA/UB-433_MG/2008/G2P[4]
b
 RVA/Human-wt/ZAF/MRC-DPRU1362/2007/G2P[4]_KJ753609
 RVA/Human-wt/ITA/SS65/2011/G8P[4]_KC870013
 RVA/Human-wt/DEU/GER1H/2009/G8P[4]_GQ414544
 RVA/Human-wt/BRA/IP-447_MG/2011/G8P[4]
 RVA/Human-wt/BRA/UB-299_MG/2007/G2P[4]
 RVA/Human-wt/AUS/CK20036/2007/G2P[4]_KC443525
 RVA/Human-wt/PRY/1071SR/2005/G2P[4]_KJ627165
 RVA/Human-wt/BRA/UB-239_MG/2006/G2P[4]
 RVA/Human-wt/USA/LB2744/2005/G2P[4]_HM467947
 RVA/Human-wt/BRA/UB-154_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-170_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-226_MG/2006/G2P[4]
 RVA/Human-wt/BRA/IP-71_MG/2008/G2P[4]
 RVA/Human-wt/BRA/MA19557/2011/G2P[4]_KJ721697
a
Lineage VII
 RVA/Human-wt/AUS/CK20039/2008/G1P[8]_KC443602
 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]_GU565067
Lineage III
 RVA/Human-tc/USA/DS-1/1976/G2P1B[4]_DQ870507
 RVA/Human-wt/CHN/TB-Chen/1996/G2P[4]_AY787645
Lineage I
I2
 RVA/Human-tc/JPN/AU-1/1982/G3P3[9]_DQ490538
 RVA/Human-tc/THA/T152/1998/G12P[9]_DQ146702
 RVA/Human-wt/BRA/PE18974/2010/G12P[9]_KF907299
 RVA/Human-wt/PRY/1471SR/2006/G12P[9]_KJ412579
 RVA/Human-wt/BRA/UB-144_MG/2006/G12Px
 RVA/Human-wt/BRA/UB-150_MG/2006/G12Px
I3
 RVA/Human-tc/USA/Rotarix/2009/G1P[8]_JX943613
 RVA/Human-tc/USA/Wa/1974/G1P1A[8]_K02086
 RVA/Human-tc/JPN/KU/1974/G1P1[8]_AB022768
 RVA/Human-wt/BRA/UB-146_MG/2006/G12P[8]
 RVA/Human-wt/BRA/UB-208_MG/2006/G9P[8]
 RVA/Human-wt/BRA/UB-142_MG/2006/GxP[8]
 RVA/Human-wt/BRA/RJ12419/2006/G12P[8]_KF907300
 RVA/Human-wt/USA/VU05-06-2/2005/G1P[8]_JF490563
 RVA/Human-wt/KOR/Hu/CI-81/2011/G1P8]_JN887819
 RVA/Human-wt/BEL/BE00004/2005/G1P[8]_HQ392007
 RVA/Human-wt/AUS/CK00086/2009/G1P[8]_JX027852
 RVA/Human-wt/BRA/UB-558_MG/2011/G9P[8]
 RVA/Human-wt/ZAF/MRC-DPRU1311/2007/G1P[X]_KJ753053
 RVA/Human-wt/BRA/UB-16/2005/G9P[8]
 RVA/Human-wt/BRA/UB-157_MG/2006/G9P[8]
 RVA/Human-wt/BRA/UB-169_MG/2006/G9P[8]
 RVA/Human-wt/BEL/BE00017/2006/G1P[8]_HQ392118
 RVA/Human-wt/CMR/ES283/2010/G12P[6]_KM660367
 RVA/Human-wt/AUS/CK00089/2009/G1P[8]_JX027886
 RVA/Human-wt/PRY/467/2000/G9P[8]_KJ626909
 RVA/Human-wt/CAN/RT034-07/2007/G9P8_JQ069553
 RVA/Human-wt/IND/CRI_32609/xxxx/G12P[6]_DQ909062
 RVA/Human-wt/BRA/rj8200/2004/G1P8_DQ498163
 RVA/Human-wt/BRA/UB-09_MG/2005/G1P[8]
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train detected in 2007 in South Africa26 and with a human
razilian strain, 12389 06RJ (99.0–100% nt and 99.4–100% aa
dentity), detected in 2006.27 These four strains did not group
ith any cluster of the previously established lineages.16 The
M E1 samples shared 91.7–100% and 92.8–100% nt and aa
dentity, respectively, and the majority of the strains had the
[8] genotype. The TM E3 samples showed 88.7% and 94.0% nt
nd aa identity, respectively. They grouped with strains that
ad genotype P[9] combined with G3, G6, or G12.tinued)
Based on the NSP5 gene, the TM samples were distributed
among the H1, H6, H3, and H2 genotypes (Fig. 1e). The TM H1
samples shared nt and aa identities in the ranges of 97.3–100%
and 99.0–100%, respectively. They grouped with ﬁeld samples
of P[8] speciﬁcity and clustered apart from the prototypes, Wa
TMand KU, and the vaccine-derived (Rotarix ) strain. The nt
identity with these reference strains was 92.3–100%, and the
aa identity was 93.9–100%. The TM H6 samples were identical
and clustered together with samples exhibiting the G12P[9]
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 RVA/Human-wt/ITA/PA150/2006/G2P[4]_KC178748
 RVA/Human-wt/AUS/CK20036/2007/G2P[4]_KC443519
 RVA/Human-wt/USA/LB2744/2005-6/G2P[4]_HM467979
 RVA/Human-wt/RUS/Nov04-H391/2004/G2P[4]_GQ465006
 RVA/Human-wt/BRA/UB-170_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-154_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-299_MG/2007/G2P[4]
 RVA/Human-wt/BRA/MS11142/2005/G2P[4]_KJ721749
 RVA/Human-wt/PRY/1613SR/2008/G2P[4]_KJ412773
a
 RVA/Human-wt/BRA/UB-432_MG/2008/G2P[4]
 RVA/Human-wt/BRA/IP-71_MG/2008/G2P[4]
 RVA/Human-wt/BRA/RJ12225/2006/G2P[4]_KJ721747
 RVA/Human-wt/BRA/IP-346_MG/2010/G2P[4]
 RVA/Human-wt/BRA/UB-320_MG/2007/G2P[4]
 RVA/Human-wt/BRA/UB-354_MG/2007/G2P[4]
b
 RVA/Human-wt/CHN/Tb-Chen/1996/G2P[4]_AY787650
Lineage VI
Lineage V
 RVA/Human-wt/ITA/PAI11/1996/G2P[4]_KC178746
 RVA/Human-tc/USA/DS-1/1976/G2P1B[4]_AF174305
 RVA/Human-wt/AUS/CK20001/1977/G2P[4]_KC443585 Lineage I
Lineage III
 RVA/Human-tc/KEN/D205/1989/G2P[4]_JF304924
 RVA/Human-wt/COD/DRC86/2003/G8P[6]_DQ005115S02
 RVA/Human-wt/COD/DRC88/2003/G8P[8]_DQ005104S02 Lineage IX
Lineage VIII
 RVA/Goat-wt/BGD/GO34/1999/G6P[1]_GU937886
 RVA/Human-wt/BRA/IP-38_MG/2008/G2P[4]
 RVA/Human-wt/USA/2007719869/2007/G2P[4]_KC442879
 RVA/Human-wt/SEN/MRC-DPRU1915/2008/G2P[4]_KJ753521
 RVA/Human-wt/THA/CMH028/2007/G2P[4]_JQ043301
 RVA/Human-wt/AUS/CK20027/2006/G2P[4]_KC443761
 RVA/Human-wt/ITA/PA130/2010/G2P[4]_KC178745
Lineage XII
 RVA/Human-wt/BRA/IP-393_MG/2010/G2P[4]
 RVA/Human-wt/BRA/IP-364_MG/2010/G2P[4]
 RVA/Human-wt/BRA/UB-433_MG/2008/G2P[4]
 RVA/Human-wt/BRA/15860_08RJ/2008/G2P[4]_HM066188
 RVA/Human-wt/BRA/IP-47_MG/2008/G2P[4]
 RVA/Human-wt/ITA/PA133/2011/G2P[4]_KC178753
 RVA/Human-wt/RUS/Omsk/2008/G2P[4]_GQ465023
 RVA/Human-wt/USA/2007769964/2007/G2P[4]_KC442901
 RVA/Human-wt/ZAF/MRC-DPRU309/2010/G12P[8]_KJ753546
 RVA/Human-wt/AUS/CK20040/2010/G2P[4]_KC443209
 RVA/Human-wt/DEU/GER1H-09/2009/G8P[4]_GQ414549
 RVA/Human-wt/BRA/IP-447_MG/2011/G8P[4]
Lineage X
Lineage VII
 RVA/Human-wt/HUN/Hun5/1997/G6P[14]_EF554113
Lineage XI
 RVA/Human-wt/HUN/BP1062/2004/G8P[14]_FN665697
 RVA/Cow-wt/ZAF/1603/2007/G6P[5]_JN831207
 RVA/Human-wt/BRA/12389_06RJ/2006/G2P[4]_HM123850
 RVA/Human-wt/BRA/UB-239_MG/2006/G2P[4]
 RVA/Human-wt/BRA/UB-226_MG/2006/G2P[4]
Lineage II
 RVA/Human-tc/KEN/AK26/1982/G2P[4]_JF304935
 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P7[5]_GU565072
 RVA/Cow-wt/CHN/CHLY/xxxx/G6Px_FJ972713 Lineage IV
E2
 RVA/Human-wt/BRA/UB-157_MG/2006/G9P[8]
 RVA/Human-wt/BRA/UB-208_MG/2006/G9P[8]
 RVA/Human-wt/BRA/UB-142_MG/2006/GXP[8]
 RVA/Human-wt/BRA/UB-146_MG/2006/G12P[8]
 RVA/Human-wt/BRA/RJ12419/2006/G12P[8]_KF907266
 RVA/Human-wt/USA/US6588/2005-6/G12P[8]_FJ152114
 RVA/Human-wt/AUS/CK00026/2005/G1P[8]_JF490329
 RVA/Human-wt/BEL/BE00045/2009/G1P[8]_HQ392403
 RVA/Human-wt/BRA/UB-558_MG/2011/G9P[8]
 RVA/Human-wt/ZAF/MRC-DPRU83/2011/G1P[8]_KJ752978
 RVA/Human-wt/THA/CU956-KK/2011/G1P[8]_JN706662
 RVA/Human-wt/IND/071591/2007/G2P[4][8]_GU815229
 RVA/Human-wt/BRA/UB-16_MG/2005/G9P[8]
 RVA/Human-wt/BRA/rj8200/2004/G1P[8]_DQ498193
 RVA/Human-wt/BRA/UB-09_MG/2005/G1P[8]
 RVA/Human-wt/ZAF/MRC-DPRU1381/2007/G1P[8]_KJ752693
 RVA/Human-wt/BEL/BE00035/2008/G1P[8]_HQ392304
 RVA/Human-wt/USA/2007719825/2007/G1P[8]_HM773753
 RVA/Human-wt/AUS/CK00006/2004/G1P[8]_JF490142
 RVA/Human-tc/USA/Rotarix/2009/G1P[8]_JX943607
 RVA/Human-tc/USA/Wa/1974/G1P1A[8]_K02032
 RVA/Human-wt/ZAF/MRC-DPRU411/2003/G1P[8]_KJ751578
 RVA/Human-wt/AUS/CK20019/2001/G1P[8]_KC443574
 RVA/Human-wt/PRY/186/1998/G4P[8]_KJ559236
 RVA/Human-wt/DEN/H27897/2010/G9P[4]_KP013452
 RVA/Human-wt/BRA/UB-169_MG/2006/G9P[8]
 RVA/Human-wt/CAN/5Hu/2011/GxPx_JX029833
 RVA/Human-wt/RUS/NN1354-12/2012/G4P[8]_KJ162417
 RVA/Human-wt/BRA/rj6904/2003/G1P[8]_DQ498184
E1
 RVA/Human-wt/BRA/PE15776/2008/G12P[9]_KF907268
 RVA/Human-wt/PRY/1135A/2007/G12P[9]_KJ412839
 RVA/Human-wt/BRA/UB-144_MG/2006/G12PX
 RVA/Human-tc/THA/T152/1998/G12P[9]_DQ146705
 RVA/Human-tc/JPN/AU-1/1982/G3P3[9]_D89873
 RVA/Human-wt/BRA/IP-218_MG/2009/G3P[4]
 RVA/Human-wt/BRA/RV10109/2008/G3P[9]_JQ898161
 RVA/Human-wt/ITA/PG05/2011/G6P[9]_KC152922
 RVA/Human-wt/KOR/CAU12-2-51/2012/G3P[9]_KJ187597
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 RVA/Human-wt/BRA/UB-146_MG/2006/G12P8
 RVA/Human-wt/BRA/UB-157_MG/2006/G9P8
 RVA/Human-wt/BRA/UB-142_MG/2006/GXP8
 RVA/Human-wt/BRA/UB-208_MG/2006/G9P8
 RVA/Human-wt/USA/VU05-06-28/2005/G1P8_JF490680
 RVA/Human-wt/BEL/B4633/2003/G12P8_DQ146648
 RVA/Human-wt/BRA/ac11823/2006/G9P8_FJ794031
 RVA/Human-tc/CHN/Y128/2004/G1P8_JQ087433
 RVA/Human-wt/RUS/Nov12-N3835/2012/G2G3P8_KC020047
 RVA/Human-wt/BRA/UB-558_MG/2011/G9P8
 RVA/Human-wt/ZAF/MRC-DPRU1233/2004/G1P8_KJ753661
 RVA/Human-wt/PRY/1393SR/2006/G9P8_KJ626870
 RVA/Human-wt/BRA/rs11126/2005/G9P8_FJ794025
 RVA/Human-wt/BRA/UB-16_MG/2005/G9P8
 RVA/Human-wt/BRA/UB-09_MG/2005/G1P8
 RVA/Human-wt/BEL/BE00092/2003/G1P8_KC193632
 RVA/Human-wt/USA/2007719907/2007/G1P8_HM773853
 RVA/Human-wt/RUS/Nov12-N3895/2012/G9P8_KF680477
 RVA/Human-wt/PRY/1679SR/2008/G1P8_KJ412641
 RVA/Human-wt/BEL/BE00018/2006/G1P8_HQ392126
 RVA/Human-wt/BRA/ro13270/2006/G9P8_FJ794036
 RVA/Human-wt/BRA/UB-169_MG/2006/G9P8
 RVA/Human-tc/JPN/KU/1974/G1P8_AB022773
 RVA/Human-tc/USA/Wa/1974/G1P8_AF306494
 RVA/Human-tc/USA/Rotarix/2009/G1P8_JX943608
H1
 RVA/Human-wt/PRY/PY1135ASR06/2007/G12P9_FJ941115
 RVA/Human-wt/BRA/UB-150_MG/2006/G12PX
 RVA/Human-wt/BRA/UB-144_MG/2006/G12PX
 RVA/Human-wt/BRA/PE15776/2008/G12P9_KF907273
 RVA/Human-tc/THA/T152/1998/G12P9_DQ146706
 RVA/Simian-tc/USA/RRV/1975/G3P3_HQ665467
H6
 RVA/Human-tc/JPN/AU-1/1982/G3P9_AB008656
 RVA/Vaccine/USA/RotaTeq-SC2-9/1992/G2P5_GU565073
 RVA/Human-wt/BRA/IP-218_MG/2009/G3P4
 RVA/Human-wt/BRA/RV10109/2008/G3P9_JQ715680
 RVA/Cat-wt/ITA/BA222/2005/G3P9_GU827416
 RVA/Human-tc/KOR/CAU12-2-51/2012/G3Px_KJ187598
 RVA/Human-wt/JPN/KF17/2010/G6P9_JF421985
H3
 RVA/Human-tc/KEN/AK26/1982/G2P4_JF304936
 RVA/Human-tc/ITA/PAI11/1996/G2P4_KC178755
Lineage II
Lineage I
 RVA/Human-tc/USA/DS-1/1976/G2P4_M33608
 RVA/Human-wt/CHN/Tb-Chen/1996/G2P4_AY87651
 RVA/Human-wt/BRA/UB-433_MG/2008/G2P4
 RVA/Human-wt/BRA/IP-47_MG/2008/G2P4
 RVA/Human-wt/BGD/MMC88/2005/G2P4_HQ641372
 RVA/Human-wt/ITA/PA133/2011/G2P4_KC178762
 RVA/Human-wt/USA/VU08-09-8/2008/G2P4P8_KC442950
 RVA/Human-wt/AUS/CK20046/2010/G2P4_KC443641
 RVA/Human-wt/BRA/ES16238/2009/G2P4_KJ21733
 RVA/Human-wt/BRA/IP-364_MG/2010/G2P4
 RVA/Human-wt/BRA/IP-393_MG/2010/G2P4
 RVA/Human-wt/USA/2007719869/2007/G2P4_KC442880
 RVA/Human-wt/BRA/IP-38_MG/2008/G2P4
 RVA/Human-wt/BRA/IP-346_MG/2010/G2P4
 RVA/Human-wt/BRA/RJ17745/2010/G2P4_KJ721731
b
 RVA/Human-wt/AUS/CK20036/2007/G2P4_KC443520
 RVA/Human-wt/BRA/UB-432_MG/2008/G2P4
 RVA/Human-wt/BRA/IP-71_MG/2008/G2P4
 RVA/Human-wt/BRA/UB-354_MG/2007/G2P4
 RVA/Human-wt/PRY/1613SR/2008/G2P4_KJ412774
 RVA/Human-wt/BRA/UB-239_MG/2006/G2P4
 RVA/Human-wt/BRA/UB-299_MG/2007/G2P4
 RVA/Human-wt/BRA/IP-447_MG/2011/G8P4
 RVA/Human-wt/ITA/SS65/2011/G8P4_KC870018
 RVA/Human-wt/DEU/GER1H-09/2009/G8P4_GQ414550
 RVA/Human-wt/ZAF/MRC-DPRU618/2003/G2P4_KJ753356
 RVA/Human-wt/THA/CU438-KK/2009/G2P4_JN706669
 RVA/Human-wt/BRA/UB-226_MG/2006/G2P4
 RVA/Human-wt/BRA/UB-170_MG/2006/G2P4
 RVA/Human-wt/BRA/MS11142/2005/G2P4_KJ721739
 RVA/Human-wt/USA/LB2772/2005-6/G2P4_HM467921
 RVA/Human-wt/BRA/UB-154_MG/2006/G2P4
a
Lineage III
H2
93
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96
99
82
97
99
86
72
73
74
72
71
93
98
77
79
99
87
80
73
0.05
d   NSP4 e   NSP5 
(ConFig. 1 – 
combination. They were closely related (nt identity, 94.3%; aa
identity, 98.5%) to a simian RVA strain (RRV). The TM H3 sample
(IP-218) grouped apart from the prototype (AU-1) and vaccine
(RotaTeqTM) strains, with which it showed the nt identity of
93.3–95.2% and the aa identity of 92.9–96.0%. At the same time,
sample IP-218 showed high nt (98.7%) and aa (97.5%) identities
with a cat sample (BA222) of G3P[9] speciﬁcity. The TM H2 sam-
ples shared the nt identity of 97.2–99.9% and the aa identity
of 98.5–100%. They grouped with P[4] strains into two main
sub-clusters (a and b) within lineage III.
The classiﬁcation of the TM samples by genotypes, lin-
eages, and sublineages on the basis of phylogenetic analysis oftinued).
the ﬁve studied genes is summarized in Table 2. When analyz-
ing the TM samples according to their genotypes, four types
of combinations (or genetic constellations) could be observed.
The ﬁrst one consisted of samples that exhibited genotypes
G1, G9, or G12 associated with P[8]-I1-E1-H1 and had long elec-
tropherotypes. The second one was composed of samples that
showed genotypes G2 or G8 associated with P[4]-I2-E2-H2 and
had short electropherotypes. The third one included samples
exhibiting the G12 genotype combined with I3-E3-H6 and hav-
ing long electropherotypes, and the fourth one was formed by
a sample with genotype G3 associated with P[4]-I2-E3-H3 and
having a long electropherotype (Table 2).
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Table 2 – Epidemiological data, genotypes, lineages, and sublineages of Triângulo Mineiro rotavirus A strains, based on the VP7, VP8*, VP6, NSP4, and NSP5 genes.
Name of the strainsa Patients
age
Origin Month-year
of collection
Electropherotype Genotypes Lineages and sublineages
VP7 VP8* VP6 NSP4 NSP5 VP7 VP8* VP6 NSP4 NSP5
Uberaba
RVA/Human-wt/BRA/UB-09 MG/2005/G1P[8] 1 year Inpatient (HC) Sep-2005 Long G1 P[8] I1 E1 H1 I-A 3.1 – – –
RVA/Human-wt/BRA/UB-16 MG/2005/G9P[8] 2 years Inpatient (HC) Sep-2005 Long G9 P[8] I1 E1 H1 III 3.1 – – –
RVA/Human-wt/BRA/UB-142 MG/2006/GxP[8] 2 years Outpatient Jul-2006 Long Gx P[8] I1 E1 H1 – 3.1 – – –
RVA/Human-wt/BRA/UB-144 MG/2006/G12Px 1 year Outpatient Aug-2006 Long G12 Px I3 E3 H6 II – – – –
RVA/Human-wt/BRA/UB-146 MG/2006/G12P[8] 11 months Outpatient Aug-2006 Long G12 P[8] I1 E1 H1 III 3.1 – – –
RVA/Human-wt/BRA/UB-150 MG/2006/G12Px 4 years Outpatient Aug-2006 Long G12 Px I3 Ex H6 II – – – –
RVA/Human-wt/BRA/UB-157 MG/2006/G9P[8] 1 year Outpatient Aug-2006 Long G9 P[8] I1 E1 H1 III 3.1 – – –
RVA/Human-wt/BRA/UB-169 MG/2006/G9P[8] 1 year Inpatient (HC) Aug-2006 Long G9 P[8] I1 E1 H1 III 3.6 – – –
RVA/Human-wt/BRA/UB-208 MG/2006/G9P[8] 1 year Outpatient Sep-2006 Long G9 P[8] I1 E1 H1 III 3.1 – – –
RVA/Human-wt/BRA/UB-558 MG/2011/G9P[8] 23 months Inpatient (HC) Dec-2011 Long G9 P[8] I1 E1 H1 III 3.3 – – –
RVA/Human-wt/BRA/UB-154 MG/2006/G2P[4] 3 years Outpatient Aug-2006 Short G2 P[4] I2 E2 H2 IVa-1 IVa VIIa VIa IIIa
RVA/Human-wt/BRA/UB-170 MG/2006/G2P[4] 8 months Inpatient (HC) Aug-2006 Short G2 P[4] I2 E2 H2 IVa-1 IVa VIIa VIa IIIa
RVA/Human-wt/BRA/UB-226 MG/2006/G2P[4] 5 months Outpatient Sep-2006 Short G2 P[4] I2 E2 H2 IVa-1 IVa VIIa – IIIa
RVA/Human-wt/BRA/UB-239 MG/2006/G2P[4] 1 year Outpatient Oct-2006 Short G2 P[4] I2 E2 H2 IVa-1 IVa VIIa – IIIa
RVA/Human-wt/BRA/UB-299 MG/2007/G2P[4] 1 year Inpatient (HC) Jun-2007 Short G2 P[4] I2 E2 H2 IVa-1 IVa VIIa VIa IIIa
RVA/Human-wt/BRA/UB-320 MG/2007/G2P[4] 11 months Inpatient (HC) Aug-2007 Short G2 P[4] I2 E2 Hx IVa-3 IVa VIIb VIb –
RVA/Human-wt/BRA/UB-354 MG/2007/G2P[4] 1 year Inpatient (HC) Oct-2007 Short G2 P[4] I2 E2 H2 IVa-3 IVa VIIb VIb IIIa
RVA/Human-wt/BRA/UB-432 MG/2008/G2P[4] 1 year Inpatient (HC) Sep-2008 Short G2 P[4] I2 E2 H2 IVa-3 IVa VIIb VIb IIIa
RVA/Human-wt/BRA/UB-433 MG/2008/G2P[4] 4 years Outpatient Sep-2008 Short G2 P[4] I2 E2 H2 IVa-3 IVb VIIb X IIIb
Uberlândia
RVA/Human-wt/BRA/IP-38 MG/2008/G2P[4] 3 years Inpatient (HSG) Aug-2008 Short G2 P[4] I2 E2 H2 IVa-3 IVb VIIb XII IIIb
RVA/Human-wt/BRA/IP-47 MG/2008/G2P[4] 3 years Inpatient (HM) Sep-2008 Short G2 P[4] I2 E2 H2 IVa-3 IVb VIIb X IIIb
RVA/Human-wt/BRA/IP-71 MG/2008/G2P[4] 2 years Inpatient (HSG) Nov-2008 Short G2 P[4] I2 E2 H2 IVa-3 IVa VIIa VIb IIIa
RVA/Human-wt/BRA/IP-346 MG/2010/G2P[4] 1 year Inpatient (HM) May-2010 Short G2 P[4] I2 E2 H2 IVa-3 IVb VIIb VIb IIIb
RVA/Human-wt/BRA/IP-364 MG/2010/G2P[4] 2 years Inpatient (HSG) Jul-2010 Short G2 P[4] I2 E2 H2 IVa-1 IVb VIIb X IIIb
RVA/Human-wt/BRA/IP-393 MG/2010/G2P[4] 6 months Outpatient Sep-2010 Short G2 P[4] I2 E2 H2 IVa-3 IVb VIIb X IIIb
RVA/Human-wt/BRA/IP-218 MG/2009/G3P[4] 4 years Outpatient Sep-2009 Long G3 P[4] I2 E3 H3 III IVa VIIb – –
RVA/Human-wt/BRA/IP-447 MG/2011/G8P[4] 5 years Outpatient Jan-2011 Short G8 P[4] I2 E2 H2 II IVa VIIa X IIIa
UB, Uberaba; IP, Uberlândia; HC, Hospital da Crianc¸a; HSG, Hospital Santa Genoveva; HM, Hospital Madrecor; x, was not possible to amplify.
a Name of RV strains according to the nomenclature proposed by Matthijnssens et al.25
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According to the clustering patterns of the TM G2P[4] sam-
ples in the dendrograms for different genes, shown in Fig. 1,
some samples always grouped together within the same clus-
ters. However, other samples changed their grouping patterns,
clustering with different samples depending on the gene,
which is suggestive of intra-genotypic reassortment in par-
ticular genes. This was observed for strains IP-364 (VP7 gene),
UB-354, UB-432, UB-320, and IP-71 (VP8* gene), IP-71 and IP-393
(VP6 gene), IP-346, UB-239, and UB-226 (NSP4 gene), and UB-
354, UB-432, and IP-71 (NSP5 gene). Strains UB-154, UB-170,
UB-299, IP-47, UB-433, and IP-38 are probably non-reassortant
strains, at least with regard to the genes studied.
Discussion
In the TM samples, genotype G2 was found to be always
associated with the P[4], I2, E2, and H2 genotypes, whereas
the G1 and G9 genotypes were combined with the P[8]-
I1-E1-H1 genotypes (Table 2). The genotype combination
G2-P[4]-I2-E2-H2 is characteristic of the DS-1-like genotype
constellation, while G1-P[8]-I1-E1-H1 and G9-P[8]-I1-E1-H1 are
typical combinations of the Wa-like genotype constellation.
These two genotype constellations are found most commonly
worldwide.28
Despite having a typical DS-1-like constellation for all
genes, the TM G2P[4] samples were shown to belong to lin-
eages distinct from that of the DS-1 prototype strain, as
already reported for contemporary samples.16,27,29 Based on
the VP7 gene, the G2P[4] samples were detected within sub-
lineage IVa (Fig. 1a). This sublineage emerged in the 1990s and
rapidly became the most common sublineage found around
the world. The spread of this sublineage was associated with
an amino acid substitution from aspartic acid (found in the
DS-1 prototype strain) to asparagine at residue 96 (D96N) and
with the occurrence of reassortment events in G2 strains.29
These two mechanisms of variability were also observed in
this study (aa data not shown).
Sublineage G2P[4]-IVa-1 of VP7 was found from August 2006
to June 2007 in samples from hospitalized patients and outpa-
tients from Uberaba, followed by the detection of sublineage
IVa-3 since August 2007 (Table 2). In Uberlândia, all sam-
ples belonged to sublineage IVa-3, except IP-364. Sublineages
IVa and IVb of the VP8* gene also seemed to have emerged
consecutively in Uberaba. This apparent pattern of tempo-
ral segregation of the sublineages of the VP7 and VP8* genes
has also been described in other regions of Brazil and for Ital-
ian samples.16,27 An apparent temporal segregation within the
G2P[4] lineages from Uberaba was also observed for the VP6,
NSP4, and NSP5 genes. Therefore, based on the analyses of
the ﬁve genes, it seems that a new genetic variant exhibiting
the combination of sublineages IVa-3 (VP7), IVb (VP8*), VIIb
(VP6), X (NSP4), and IIIb (NSP5) began circulating in Uberaba
in September 2008 (UB-433) and was also detected in Septem-
ber 2008 (IP-47) and in September 2010 (IP-393) in Uberlândia,
corroborating the results obtained by Gómez et al. who char-
acterized circulation of a new lineage in the southeast region
of Brazil.27
Samples UB-226 and UB-239 shared high identity in the
NSP4 gene with a cow strain (1603). This result is in agreement b i o l o g y 4 7 (2 0 1 6) 731–740
with the ﬁndings of Matthijnssens et al. who revealed a com-
mon  origin between human DS-1-like and bovine strains.30
The G8 genotype is believed to be of bovine origin, but
strains with this genotype were also isolated from several
other hosts, including humans, and have been detected spo-
radically in Brazil.3 The TM G8 sample (IP-447) is closely
related to other human RVA strains, such as SS56 from Italy20
and GER1H-09 from Germany,31 sharing the same G8-II lin-
eage. There is evidence that strains of this lineage do not
represent a result of recent interspecies transmission,20,31
contrary to what was seen with some G8 strains iden-
tiﬁed in Brazilian Indian children.32 The TM G8 sample
(IP-447) was genotyped as P[4]-I2-E2-H2, and based on the ﬁve
genes it was associated with sample GER1H-09, which was
described as probably representing an intergenotypic reassor-
tant sample between the G8 genotype and human DS-1-like
rotaviruses.31
Analysis of the VP7 gene showed that the TM G1P[8] sample
(UB-09) detected in 2005, i.e., before the RotarixTM intro-
duction, belonged to lineage I, which, along with lineage II,
represents the most prevalent lineages since the 1990s in
Brazil. Through phylogenetic analysis of the VP8* gene, it
was possible to verify that UB-09 belonged to lineage P[8]-3,
which is believed to be the only lineage currently circulating
in Brazil.33 This sample fell into sublineage P[8]-3.1, which has
been shown to be most prevalent in Brazil in recent years.22
The phylogenetic analysis of the VP7 gene from the TM
G9 strains revealed that they belonged to lineage III and were
closely related to strains detected on at least three continents.
These results are in agreement with previous ﬁndings that
showed the worldwide spread of this lineage.34 When ana-
lyzing the VP8* gene, circulation of three sublineages (P[8]-3.6,
P[8]-3.3, and P[8]-3.1) was observed in the TM region. Sublin-
eage P[8]-3.6 was only observed in Brazil after the introduction
of the RotarixTM vaccine.22
Genotype G12 was ﬁrst detected in the fecal matter of chil-
dren from Philippines in 1987. It had not been reported for
about 10 years and then rapidly spread globally. It is believed
that lineage III was the main lineage responsible for the spread
of G12 worldwide.34 This lineage has been reported to be found
most often in combination with the P[6] or P[8] genotypes.28
One TM G12 sample (UB-146) was found to belong to this lin-
eage and to have the P[8]-I1-E1-H1 genotype combination. This
allele combination (Wa-like) is most commonly found for G12,
but this genotype can also be found, although at a much lower
frequency, associated with P[9]-I3-E3-H3, which are AU-1-like
genotypes.28 Two other TM G12 samples (UB-144 and UB-150)
presented AU-1-like genotypes. They also exhibited the H6
genotype, which showed a high nt identity with simian RVA;
therefore, it seems that the TM G12 samples have different ori-
gins, as has also been observed in another study from Brazil.35
TM samples UB-144 and UB-150 were closely related to ref-
erence strain T152 based on all analyzed genes, and there
is evidence that the NSP5 gene of this sample is of animal
origin.19
According to the phylogenetic trees, the G12-Px-I3-E3/x-
H6 strains probably possess P[9] speciﬁcity. The number of
non-typable RVA strains depends on the number of genotype-
speciﬁc primers used for RT-PCR genotyping. The genotyping
failure is relatively high, given today’s technology, and may
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associated with failure to serotype. J Clin Microbiol.b r a z i l i a n j o u r n a l o f m i c 
epresent a low viral load or unusual genotypes (e.g., orig-
nating from zoonotic transmission) that are not able to
e detected with the primers used.36 Furthermore, the PCR
rimers may have become outdated due to mutations in the
rimer-binding sites during co-circulation of wild-type RVAs
ver the years.37
RVAs of the G3 genotype have several hosts and are com-
only found associated with the P[8] genotype in humans.
he G3 sample of long electropherotype (IP-218) associated
ith the P[4] genotype was once detected in the region.8
lthough this combination is unusual, the G3P[4] genotype
as responsible for an outbreak of diarrhea in 1998 in Juiz
e Fora, Brazil.38 In the IP-218 sample, a combination with the
2-E3-H3 genotype was found. The evidence of reassortment
etween G3 samples and typical G2P[4] strains (P[4]-I2-E2-H2)
as already been provided39; however, to our knowledge, this
s the ﬁrst time when the combination G3-P[4]-I2-E3-H3 is
eported.
Based on the VP7 and NSP5 genes, G3 sample IP-218 fell into
he cluster of the prototype strain (AU-1) with an RVA strain
solated from cat (BA222). Based on the VP8* and VP6 genes, it
as closely related to human rotaviruses that share DS-1-like
enotypes. Therefore, the IP-218 sample probably represents
 reassortment between AU-1-like and DS-1-like strains, and
t would be interesting to characterize the other genome seg-
ents of this sample. A close relationship between human
3 RVAs and feline strains has previously been described in
razil40,41 and other countries.42
The phylogenetic analyses of the ﬁve genes from the
2P[4] strains showed that various reassortment events likely
ccurred from 2006 to 2010 in the TM region, which is consis-
ent with the ﬁndings from other studies conducted in Brazil
nd Italy.16,27 Both co-circulation of different genetic variants
nd a signiﬁcant migration ﬂow between countries con-
ribute to the occurrence of reassortment events. Interestingly,
 recent study in Nashville, TN, USA,43 described the co-
irculation of genetic variants that probably only underwent
ntigenic drifts without the occurrence of reassortments. This
isparity in results may be due to a short period (2010–2011)
xamined in the above study.
In this study, we  characterized, based on ﬁve genes, the
enetic diversity of RVA strains representative of six sea-
ons in the TM region. A great intragenotypic diversity was
bserved among the G2P[4] samples, with an apparent pattern
f temporal segregation within the lineages or sublineages.
he occurrence of intergenotypic reassortment events was
vident, leading, in particular, to a combination of genotypes
ot previously reported (G3-P[4]-I2-E3-H3). Five TM samples
ontained genes that exhibited high nt and aa identities with
trains of animal origin. These results highlight the impor-
ance of studying diversity of human and animal rotaviruses
n order to better understand the mechanisms and the fre-
uency of interspecies transmission. The data of this study
over a period pre- and post-introduction of rotavirus vacci-
ation in all Brazilian territories, thereby serving as a basis for
onitoring changes in the genetic constitution of rotaviruses.
hese changes can inﬂuence the viral ﬁtness and the effective-
ess of vaccines over time. The present study also contributes
o the understanding of the genetic diversity and evolution of
otaviruses in a global context.o l o g y 4 7 (2 0 1 6) 731–740 739
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